ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $364,045 | +12.5% | 17,767 | +9.1% | 0.02% | +19.0% |
Q2 2023 | $323,483 | +10.0% | 16,280 | -5.2% | 0.02% | +5.0% |
Q1 2023 | $294,190 | +0.9% | 17,174 | +15.2% | 0.02% | -9.1% |
Q4 2022 | $291,690 | +32.6% | 14,905 | +8.1% | 0.02% | +22.2% |
Q3 2022 | $220,000 | +19.6% | 13,791 | +3.0% | 0.02% | -5.3% |
Q2 2022 | $184,000 | +44.9% | 13,386 | +66.1% | 0.02% | +72.7% |
Q1 2022 | $127,000 | -37.1% | 8,058 | -13.3% | 0.01% | -35.3% |
Q4 2021 | $202,000 | -21.1% | 9,291 | +8.3% | 0.02% | -19.0% |
Q3 2021 | $256,000 | -32.5% | 8,577 | 0.0% | 0.02% | -44.7% |
Q2 2021 | $379,000 | +0.3% | 8,577 | +0.6% | 0.04% | -5.0% |
Q1 2021 | $378,000 | -19.4% | 8,528 | -0.4% | 0.04% | -31.0% |
Q4 2020 | $469,000 | +98.7% | 8,563 | -17.1% | 0.06% | +70.6% |
Q3 2020 | $236,000 | -3.3% | 10,330 | -11.4% | 0.03% | -10.5% |
Q2 2020 | $244,000 | +71.8% | 11,660 | +14.2% | 0.04% | +35.7% |
Q1 2020 | $142,000 | -22.0% | 10,210 | +27.6% | 0.03% | -3.4% |
Q4 2019 | $182,000 | +93.6% | 8,000 | -1.8% | 0.03% | +81.2% |
Q3 2019 | $94,000 | +9.3% | 8,150 | +41.5% | 0.02% | +6.7% |
Q2 2019 | $86,000 | – | 5,760 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |